Keywords: Bethesda assay in acquired hemophilia; acquired inhibitor in infants; management of acquired hemophilia; pregnancy-associated acquired hemophilia; transplacental transfer in postpartum acquired hemophilia; treatment of acquired inhibitor; acquired factor VIII inhibitor.